Association of L-Ficolin Levels and FCN2 Genotypes with Chronic Chagas Disease

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Luz, Paola R ^a   Boldt, Angelica B W ^a   Grisbach, Caroline ^a   Kun, Jürgen F J ^b   Velavan, Thirumalaisamy P ^b   Messias Reason, Iara J T ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FICOLIN; L FICOLIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASYMPTOMATIC INFECTION; BLOOD LEVEL; BRAZIL; CHAGAS DISEASE; CONTROLLED STUDY; EXON; FEMALE; FICOLIN 2 GENE; GASTROINTESTINAL DISEASE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HEART DISEASE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; BRAZIL; CASE-CONTROL STUDIES; CHAGAS DISEASE; CHRONIC DISEASE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; LECTINS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

TRYPANOSOMA CRUZI;

EID: 84875922033     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060237     Document Type: Article

References (42)

1. Dias JCP (2008) Eradication of Chagas Disease: What Are Its Possibilities? Report of the Scientific Meeting, Rio de Janeiro, Brazil. Ref Type: Report.
2. Ribeiro AL, Rocha MO, (1998) [Indeterminate form of Chagas disease: considerations about diagnosis and prognosis]. Rev Soc Bras Med Trop 31: 301-314.
3. Dutra WO, Gollob KJ, (2008) Current concepts in immunoregulation and pathology of human Chagas disease. Curr Opin Infect Dis 21: 287-292.
4. Kipnis TL, Joiner KA, da Silva WD, Rimoldi MT, Hammer CH, et al. (1988) Identification of membrane components of Trypanosoma cruzi modulators of complement system. Mem Inst Oswaldo Cruz 83Suppl 1: 571-575.
5. Messias-Reason IJ, Urbanetz L, Pereira da CC, (2003) Complement C3 F and BF S allotypes are risk factors for Chagas disease cardiomyopathy. Tissue Antigens 62: 308-312.
6. Luz PR, Miyazaki MI, Neto NC, Nisihara RM, Messias-Reason IJ, (2010) High levels of mannose-binding lectin are associated with the risk of severe cardiomyopathy in chronic Chagas Disease. Int J Cardiol 143: 448-450.
7. Cestari IS, Krarup A, Sim RB, Inal JM, Ramirez MI, (2009) Role of early lectin pathway activation in the complement-mediated killing of Trypanosoma cruzi. Mol Immunol 47: 426-437.
8. Boldt AB, Luz PR, Messias-Reason IJ, (2011) MASP2 haplotypes are associated with high risk of cardiomyopathy in chronic Chagas disease. Clin Immunol 140: 63-70.
9. Runza VL, Schwaeble W, Mannel DN, (2008) Ficolins: novel pattern recognition molecules of the innate immune response. Immunobiology 213: 297-306.
10. Jensen ML, Honore C, Hummelshoj T, Hansen BE, Madsen HO, et al. (2007) Ficolin-2 recognizes DNA and participates in the clearance of dying host cells. Mol Immunol 44: 856-865.
11. Hummelshoj T, Munthe-Fog L, Madsen HO, Fujita T, Matsushita M, et al. (2005) Polymorphisms in the FCN2 gene determine serum variation and function of Ficolin-2. Hum Mol Genet 14: 1651-1658.
12. Cedzynski M, Nuytinck L, Atkinson AP, St SA, Zeman K, et al. (2007) Extremes of L-ficolin concentration in children with recurrent infections are associated with single nucleotide polymorphisms in the FCN2 gene. Clin Exp Immunol 150: 99-104.
13. Munthe-Fog L, Hummelshoj T, Hansen BE, Koch C, Madsen HO, et al. (2007) The impact of FCN2 polymorphisms and haplotypes on the Ficolin-2 serum levels. Scand J Immunol 65: 383-392.
14. de Messias-Reason I, Kremsner PG, Kun JF, (2009) Functional haplotypes that produce normal ficolin-2 levels protect against clinical leprosy. J Infect Dis 199: 801-804.
15. Hoang TV, Toan NL, Song LH, Ouf EA, Bock CT, et al. (2011) Ficolin-2 levels and FCN2 haplotypes influence hepatitis B infection outcome in Vietnamese patients. PLoS One 6: e28113.
16. Faik I, Oyedeji SI, Idris Z, de Messias-Reason IJ, Lell B, et al. (2011) Ficolin-2 levels and genetic polymorphisms of FCN2 in malaria. Hum Immunol 72: 74-79.
17. Ouf EA, Ojurongbe O, Akindele AA, Sina-Agbaje OR, Van TH, et al. (2012) Ficolin-2 levels and FCN2 genetic polymorphisms as a susceptibility factor in schistosomiasis. J Infect Dis 206: 562-570.
18. Messias-Reason IJ, Schafranski MD, Kremsner PG, Kun JF, (2009) Ficolin 2 (FCN2) functional polymorphisms and the risk of rheumatic fever and rheumatic heart disease. Clin Exp Immunol 157: 395-399.
19. Cedzynski M, Atkinson AP, St SA, MacDonald SL, Szala A, et al. (2009) L-ficolin (ficolin-2) insufficiency is associated with combined allergic and infectious respiratory disease in children. Mol Immunol 47: 415-419.
20. Swierzko AS, Atkinson AP, Cedzynski M, MacDonald SL, Szala A, et al. (2009) Two factors of the lectin pathway of complement, l-ficolin and mannan-binding lectin, and their associations with prematurity, low birthweight and infections in a large cohort of Polish neonates. Mol Immunol 46: 551-558.
21. Matsushita M, Fujita T, (2002) The role of ficolins in innate immunity. Immunobiology 205: 490-497.
22. Krarup A, Mitchell DA, Sim RB, (2008) Recognition of acetylated oligosaccharides by human L-ficolin. Immunol Lett 118: 152-156.
23. Krarup A, Thiel S, Hansen A, Fujita T, Jensenius JC, (2004) L-ficolin is a pattern recognition molecule specific for acetyl groups. J Biol Chem 279: 47513-47519.
24. [Brazilian Consensus on Chagas disease], (2005) Rev Soc Bras Med Trop. 38Suppl 3: 7-29.
25. Boldt AB, Culpi L, Tsuneto LT, de Souza IR, Kun JF, et al. (2006) Diversity of the MBL2 gene in various Brazilian populations and the case of selection at the mannose-binding lectin locus. Hum Immunol 67: 722-734.
26. Ojurongbe O, Ouf EA, Van TH, Toan NL, Song LH, et al. (2012) Reliable and rapid characterization of functional FCN2 gene variants reveals diverse geographical patterns. BMC Med Genet 13: 37.
27. Boldt AB, Petzl-Erler ML, (2002) A new strategy for mannose-binding lectin gene haplotyping. Hum Mutat 19: 296-306.
28. Excoffier L, Laval G, Schneider S, (2005) Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol Bioinform Online 1: 47-50.
29. Kilpatrick DC, Fujita T, Matsushita M, (1999) P35, an opsonic lectin of the ficolin family, in human blood from neonates, normal adults, and recurrent miscarriage patients. Immunol Lett 67: 109-112.
30. Sallenbach S, Thiel S, Aebi C, Otth M, Bigler S, et al. (2011) Serum concentrations of lectin-pathway components in healthy neonates, children and adults: mannan-binding lectin (MBL), M-, L-, and H-ficolin, and MBL-associated serine protease-2 (MASP-2). Pediatr Allergy Immunol 22: 424-430.
31. Haerynck F, Van SK, Cattaert T, Loeys B, Van DS, et al. (2012) Polymorphisms in the lectin pathway genes as a possible cause of early chronic Pseudomonas aeruginosa colonization in cystic fibrosis patients. Hum Immunol 73: 1175-1183.
32. Assaf A, Hoang TV, Faik I, Aebischer T, Kremsner PG, et al. (2012) Genetic evidence of functional ficolin-2 haplotype as susceptibility factor in cutaneous leishmaniasis. PLoS One 7: e34113.
33. de Rooij BJ, van der Beek MT, van HB, Vossen AC, Rogier Ten HW, et al. (2011) Mannose-binding lectin and ficolin-2 gene polymorphisms predispose to cytomegalovirus (re)infection after orthotopic liver transplantation. J Hepatol 55: 800-807.
34. de Rooij BJ, van HB, ten Hove WR, Roos A, Bouwman LH, et al. (2010) Lectin complement pathway gene profile of donor and recipient determine the risk of bacterial infections after orthotopic liver transplantation. Hepatology 52: 1100-1110.
35. Ruskamp JM, Hoekstra MO, Postma DS, Kerkhof M, Bottema RW, et al. (2009) Exploring the role of polymorphisms in ficolin genes in respiratory tract infections in children. Clin Exp Immunol 155: 433-440.
36. Chapman SJ, Vannberg FO, Khor CC, Segal S, Moore CE, et al. (2007) Functional polymorphisms in the FCN2 gene are not associated with invasive pneumococcal disease. Mol Immunol 44: 3267-3270.
37. Vander CB, Nuytinck L, Boullart L, Elewaut D, Waegeman W, et al. (2007) Polymorphisms in the ficolin 1 gene (FCN1) are associated with susceptibility to the development of rheumatoid arthritis. Rheumatology (Oxford) 46: 1792-1795.
38. Chen X, Katoh Y, Nakamura K, Oyama N, Kaneko F, et al. (2006) Single nucleotide polymorphisms of Ficolin 2 gene in Behcet's disease. J Dermatol Sci 43: 201-205.
39. Acosta DM, Soprano LL, Ferrero M, Landoni M, Esteva MI, et al. (2011) A striking common O-linked N-acetylglucosaminyl moiety between cruzipain and myosin. Parasite Immunol 33: 363-370.
40. Aiello VD, Reis MM, Benvenuti LA, Higuchi ML, Ramires JA, et al. (2002) A possible role for complement in the pathogenesis of chronic chagasic cardiomyopathy. J Pathol 197: 224-229.
41. Ma YJ, Doni A, Hummelshoj T, Honore C, Bastone A, et al. (2009) Synergy between ficolin-2 and pentraxin 3 boosts innate immune recognition and complement deposition. J Biol Chem 284: 28263-28275.
42. Ng PM, Le SA, Lee CM, Tan NS, Lu J, et al. (2007) C-reactive protein collaborates with plasma lectins to boost immune response against bacteria. EMBO J 26: 3431-3440.